Latest Headlines

  1. Meridian Launches New qPCR Master Mixes For Stool Samples To Accelerate Development Of Molecular Assays 6/20/2022

    Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today two new sample-specific master mixes, Lyo-Ready™ Direct DNA qPCR Stool Mix, and Lyo-Ready™ Direct RNA/DNA qPCR Stool Mix.

  2. Paige Announces Collaboration To Deploy A Novel AI-Based Biomarker Test For Advanced Bladder Cancer In Clinical Settings 6/15/2022

    Paige,a global leader in clinical AI applications in pathology, today announced a collaboration with Janssen Research & Development, LLC (Janssen) to evaluate the potential of a hematoxylin and eosin (H&E)-based, artificial intelligence (AI)-powered biomarker test to predict the presence of certain actionable alterations in the fibroblast growth factor receptor (FGFR) genes in patients with advanced urothelial cancer, also known as bladder cancer.

  3. Sentinel Diagnostics Launches A Totally Automated High Throughput Analyzer For Fecal Immunochemical Testing 6/15/2022

    To fulfill the growing need of Colorectal Cancer Screening organizations and big clinical laboratories, Sentinel Diagnostics - an Italian company focused for more than 35 years on the development and production of In Vitro Diagnostics for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms - announces the launch of the SENTiFIT® 800 Analyzer, a fully automated and high throughput system for Fecal Immunochemical Test.

  4. Sysmex America Receives FDA Clearance For Residual White Blood Cell Counting 6/15/2022

    Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, has received FDA clearance for the addition of residual white blood cell counting to its XN-10 Automated Hematology Analyzer with Blood Bank mode.

  5. Ibex Obtains CE Mark For Galen Gastric, The World's First AI-Powered Solution For Gastric Cancer Detection 6/15/2022

    Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, today announced CE mark for the Galen™ Gastric solution that supports pathologists in the detection of various types of gastric cancer.

  6. Premier Medical Laboratory Services Now Offering AditxtScore™ Personalized Immune Test For COVID-19 6/14/2022

    Premier Medical Laboratory Services (PMLS), a nation leading advanced medical diagnostics lab, adds AditxtScore™ to its menu of testing services.

  7. Nanomix Receives IVDR Certification For The eLab Analyzer 6/14/2022

    Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has received the EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for its eLab analyzer, part of the Nanomix eLab® system.

  8. HALO Diagnostics And Genomic Testing Cooperative Partner To Advance Early Cancer Detection And Precision Diagnostics 6/14/2022

    HALO Diagnostics, a precision diagnostics leader, has joined forces with the Genomic Testing Cooperative (GTC) to offer innovative, personalized testing to its physician network and 1M+ patients served.

  9. Todos Medical Completes Validation Of 27 Pathogen UTI PCR Panel At Its CLIA/CAP Laboratory Provista Diagnostics 6/13/2022

    Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has completed validation of a 27-pathogen urinary tract infection (UTI) PCR precision medicine panel.

  10. Scopio Labs Awarded FDA Clearance For High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes With Digitization 6/9/2022

    Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, announced today that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance.